Search & Filter

The European Medicines Agency (EMA) has announced it plans to tackle the rise of antimicrobial resistance by speeding up the development of new treatments, promoting the responsible use of antibiotics and antimicrobials and improving data to advise policy and research.

New research recently published in the Movement Disorders journal by the International Parkinson and Movement Disorder Society's (MDS) Task Force on Definition of Parkinson's Disease outlines newly updated clinical diagnostic criteria for Parkinson's disease (PD) as well as the first-ever produced criteria for prodromal PD. 

The Lullaby Trust has welcomed the Government's pledge to halve stillbirths, neonatal and maternal deaths, following an announcement by Jeremy Hunt.

New findings from a health economics and outcomes research (HEOR) analysis demonstrated that liraglutide 1.2mg (Victoza) is cost-effective for the treatment of type 2 diabetes in the UK market when compared to lixisenatide and is cost-saving compared to exenatide.

An app which turns a smartphone into a diabetes monitor and management platform to track key statistics has been launched ahead of World Diabetes Day.

New figures released this week show that the 62-day-wait target for cancer treatment has failed to be met for the seventh consecutive quarter in England.

The National Audit of Intermediate Care's 2015 report has been published, revealing that older people are waiting longer for access to intermediate care services. Waiting times now average 3 days for bed based care, 6.3 days for home based services, and 8.7 days for re-ablement.

New data presented at this year's Society for Endocrinology BES conference[4 November] has revealed that Testosterone Deficiency Syndrome (TDS) is underdiagnosed and undertreated despite its high prevalence in older men and those with various comorbidities.

The Scottish Medicines Consortium has announced that edoxaban (Lixiana) will be available to Scottish patients to treat venous thromboembolism (VTE), which covers both pulmonary embolism (PE) and deep vein thrombosis (DVT). 

Digital technology expert bITjAM is working in conjunction with the North Staffordshire Combined Healthcare NHS Trust to design and develop new technological innovations to aid suffers of mild cognitive impairment.

New research has revealed that eight in 10 GPs are not confident their older patients are still taking their medicines correctly six months after consultation.

A South Yorkshire-based NHS Trust has developed a resource folder for GPs packed with useful information to support people with learning disabilities.

This week's World Stroke Day used the theme is 'I am woman' to highlight the fact that women are not only at higher risk of stroke, but are also more likely to die from the condition compared to men.

A comprehensive new resource to support health and social care staff and educators who work with people living with dementia and their carers has been launched.

The European Medicines Agency (EMA) has recommended authorising talimogene laherparepvec (Imlygic) for the treatment of adults with melanoma that cannot be removed by surgery and that has spread either to the surrounding area or to other areas of the body without affecting the bones, brain, lung or other internal organs.